VIEWPOINT MOLECULAR TARGETING, INC.: Antibody-based prertargeted alpha particle therapy for ovarian cancer

VIEWPOINT MOLECULAR TARGETING, INC. (Coralville, Iowa): Antibody-based prertargeted alpha particle therapy for ovarian cancer. Its award of $1,006,109 is above the median of $407,048 (87th percentile). Dated 49 days ago, it serves as a historical benchmark. Score 70/100. As of 2026-11-03, from NIH RePORTER (newly awarded projects).

Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)

award: $1,006,109 · 87th percentile of 10,712 NihBiotechGrantPulse records · 2.5x the median

Free preview: all 10 published fields of this record are shown below. Locked: 67 related IA NihBiotechGrantPulse records and the 5-column CSV export.

FieldValue
OrganizationVIEWPOINT MOLECULAR TARGETING, INC.
LocationCoralville, IA
ProjectAntibody-based prertargeted alpha particle therapy for ovarian cancer
Project number4R42CA287696-02
MechanismR42
InstituteNational Cancer Institute
Award$1,006,109
Awarded2026-09-17
Project period2024-06-05 to 2028-06-30
UEIRDZCK3F6AU73
award percentile87th of 10,712 (median $407,048, 2.5x median)
Peer records CSV (68 IA records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch VIEWPOINT MOLECULAR TARGETING, INC.

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Free first: a 10-record sample of IA records

See the real columns before you buy. One confirmation email, nothing else unless you opt in.

Unlock VIEWPOINT MOLECULAR TARGETING + all 68 IA records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · State · Institute · Award · Awarded · official source URL

  • Source agency: NIH RePORTER (newly awarded projects)
  • Record date: 2026-09-17
  • Data refreshed: 2026-11-03
  • Refunds on request within 14 days

Search all IA records free →

Top NihBiotechGrantPulse records (IA first): UNIVERSITY OF IOWA · IOWA ONCOLOGY RESEARCH ASSOCIATION · UNIVERSITY OF IOWA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · MASSACHUSETTS GENERAL HOSPITAL · Browse all by state and category →

LIVE PUBLIC DATA Source: NIH RePORTER (newly awarded projects) · Last refreshed: Tue, 03 Nov 2026 18:16:24 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Peer benchmark and outreach value: VIEWPOINT MOLECULAR TARGETING, INC. and 68 Iowa peers

  • Iowa NihBiotechGrantPulse records like this one: 68
  • VIEWPOINT MOLECULAR TARGETING, INC.'s award: 87th percentile of 10,712 records
  • Timing: Low: older than 30 days
  • Estimated pipeline if you contact every Iowa peer: $13,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

Search, filter and export more NihBiotechGrantPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

70 / 100 Lab Budget Score

  • Award of $1M or more.
  • Research or center grant: supplies, instruments and services budget.

What is the NihBiotechGrantPulse record for VIEWPOINT MOLECULAR TARGETING, INC. in Coralville, Iowa?

VIEWPOINT MOLECULAR TARGETING, INC. received an NIH award of $1,006,109 on 2026-09-17: Antibody-based prertargeted alpha particle therapy for ovarian cancer.

How does VIEWPOINT MOLECULAR TARGETING, INC. compare to other Iowa NihBiotechGrantPulse records?

Its award of $1,006,109 sits in the upper half (87th percentile) of 10,712 records; the median is $407,048. It is 49 days old; check the official source for later updates before acting. Its Lab Budget Score of 70/100 puts it among the stronger signals in this feed.

VIEWPOINT MOLECULAR TARGETING, INC. vs. top 3 peers

OrganizationLocationAmountPercentileRecord dateCompare
VIEWPOINT MOLECULAR TARGETING, INC.Coralville, IA1,006,10987th2026-09-17This record
UNIVERSITY OF IOWAIOWA CITY, IA1,037,50188th2026-09-18Compare VIEWPOINT MOLECULAR TARGETING, INC. vs UNIVERSITY OF IOWA →
UNIVERSITY OF IOWAIOWA CITY, IA1,098,76389th2026-09-02View record →
UNIVERSITY OF IOWAIOWA CITY, IA1,166,25090th2026-08-31View record →

Compare VIEWPOINT MOLECULAR TARGETING, INC. vs IOWA ONCOLOGY RESEARCH ASSOCIATION →

Related records

NihBiotechGrantPulse: records in Iowa NihBiotechGrantPulse: Small business SBIR/STTR (R41-R44, U43-U44)

More Iowa public-record feeds

Newly Posted IRS Automatic Revocations of Tax Exemption in Iowa CMS HAC Reduction & Readmissions Penalties by Hospital in Iowa New Grants by Vendor Procurement Need in Iowa New SBA 7(a) & 504 Loan Approvals in Iowa New NSF Research Awards by Institution in Iowa Carrier Out-of-Service Alerts in Iowa Nursing Home Inspection Deficiencies by State & Severity in Iowa Newly CLIA-Certified Laboratories by State & Certificate in Iowa

How to monitor VIEWPOINT MOLECULAR TARGETING, INC. and peer small business sbir/sttr (r41-r44, u43-u44) records

Get new NihBiotechGrantPulse records like VIEWPOINT MOLECULAR TARGETING, INC. by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get newly funded labs in your territory

NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.

Often used together